Remus Pharmaceuticals (REMUS) Share Price rises 8.61% as stock trades at Rs 930

Remus Pharmaceuticals Share Price is trading at Rs 930, up 8.61% from the previous close of Rs 856.25, while market capitalisation stands at Rs 995.1 Cr. According to latest Univest data, the move is confirmed, but no company-specific catalyst is established. For readers tracking Remus Pharmaceuticals Share Price today, the key takeaway is simple: the stock opened at Rs 883, moved to a high of Rs 950 and a low of Rs 883, and is trading well above the prior close as of 08 October 2026 at 9:52:54 AM IST. In Univest terms, this is a clear price rise event that puts Remus Pharmaceuticals Share Price into focus for investors following stock news, valuation context and sector comparison.

The latest Univest figures also place the move in a broader context for Remus Pharmaceuticals Share Price news. The day change is Rs 73.75, and the current print remains close to the intraday high. That makes the price action relevant even without a verified trigger. The next sections of this Remus Pharmaceuticals Share Price article focus on price action, fundamental analysis and the Trading sector backdrop, so investors can track the stock with facts rather than assumptions.

Remus Pharmaceuticals Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 930
Previous Close	Rs 856.25
Today's Move	Rs 73.75 (+8.61%)
Open	Rs 883
High	Rs 950
Low	Rs 883
Market Capitalisation	Rs 995.1 crore
Market Cap Category	Micro Cap

Remus Pharmaceuticals Ltd. (REMUS) rose to Rs 930 from the previous close of Rs 856.25, a move of Rs 73.75 or 8.61%. The stock opened at Rs 883, reached a high of Rs 950, recorded a low of Rs 883.

Remus Pharmaceuticals Share Price today shows a firm intraday rise, with the stock moving from Rs 883 at the open to Rs 930 in the latest trade. The share price gain is Rs 73.75, or 8.61%, versus the previous close, and the stock has already touched Rs 950 during the morning session. For anyone checking Remus Pharmaceuticals Share Price live, the day’s range so far runs from Rs 883 to Rs 950.

That price action matters because Remus Pharmaceuticals Share Price is trading above both the open and the prior close, even though no company-specific catalyst is established. The current market capitalisation of Rs 995.1 Cr also places the stock in a clearly defined size bracket for today’s move. In Univest coverage, the Remus Pharmaceuticals Share Price update is therefore best read as a verified price rise first, with the rest of the analysis built around the numbers rather than assumptions. From here, the focus shifts to Remus Pharmaceuticals Share Price fundamental analysis.

Remus Pharmaceuticals Ltd. (REMUS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 995.1 crore
P/E Ratio	27.28x
P/B Ratio	2.87x
ROE	15.22%
ROCE	18.64%
EPS	Rs 31.39
Book Value Per Share	Rs 297.86
Dividend Yield	0.12%

Remus Pharmaceuticals Ltd. (REMUS) fundamental metrics show P/E 27.28x, P/B 2.87x, ROE 15.22%, ROCE 18.64%. These figures provide context only and are not a buy or sell signal.

Remus Pharmaceuticals Ltd. has a market capitalisation of Rs 995.1 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 27.28x, P/B at 2.87x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.22% and ROCE of 18.64%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 31.39, book value per share of Rs 297.86, dividend yield of 0.12%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 22.99x, median ROE of 4.09%, median ROCE of 6.09%. Taken together, they outline the fundamentals rather than a view on the stock.

Sector and Industry Context

Metric	Value
Sector	Trading
Industry	Trading
Benchmark Scope	same industry
Company P/E Ratio	27.28x
Benchmark Median P/E	22.99x
Benchmark Average P/E	108.42x
Benchmark P/E Range	0.14x to 8,514.32x
Company P/B Ratio	2.87x
Benchmark Median P/B	1.37x
Company ROE	15.22%
Benchmark Median ROE	4.09%
Company ROCE	18.64%
Benchmark Median ROCE	6.09%
Company Market Capitalisation	Rs 995.1 crore
Benchmark Median Market Cap	Rs 53.15 crore

Remus Pharmaceuticals Ltd. (REMUS) operates in the Trading sector, within the Trading industry.

Remus Pharmaceuticals Ltd. (REMUS) has a P/E ratio of 27.28x, which is above the benchmark median of 22.99x, a difference of +18.66%. On its own, the P/E gap is a valuation reference point, not a trading call.

Remus Pharmaceuticals Ltd. (REMUS) has a ROE of 15.22%, which is above the benchmark median of 4.09%, a difference of +272.13%. Remus Pharmaceuticals Ltd. (REMUS) has a ROCE of 18.64%, which is above the benchmark median of 6.09%, a difference of +206.08%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Adani Enterprises Ltd.	ADANIENT	3,85,810.94	49.9	3.94	15.07	13.3
Aegis Logistics Ltd.	AEGISLOG	49,013.64	40.95	7.76	20.71	19.76
ADITYA INFOTECH LIMITED	CPPLUS	48,745.44	104.29	14.16	25.68	29.48
Premier Energies Ltd.	PREMIERENE	41,053.1	24.86	8.71	42.6	33.72
Redington Ltd.	REDINGTON	31,716.59	18.67	2.99	13.6	18.96

Remus Pharmaceuticals Ltd. (REMUS) has a P/E ratio of 27.28x compared with the displayed peer median of 40.95x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 15.22% compares with a peer median of 20.71% across the companies shown in the table. ROCE stood at 18.64% versus the displayed peer median of 19.76%, providing a capital-efficiency comparison. Remus Pharmaceuticals Ltd. (REMUS) has a market capitalisation of Rs 995.1 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Remus Pharmaceuticals Ltd.

• Remus Pharmaceuticals Share Price is up 8.61% and is trading at Rs 930, making the intraday move easy to verify.
• The stock has moved between Rs 883 and Rs 950 today, with the current trade near the day’s upper end.
• Remus Pharmaceuticals Share Price carries a P/E of 27.28 and a P/B of 2.87, which gives the move valuation context.
• ROE of 15.22% and ROCE of 18.64% place the company above the industry median on both return metrics.
• Remus Pharmaceuticals Share Price sits in the Trading sector, so sector benchmarking and peer comparison remain important.

About Remus Pharmaceuticals Ltd.

Remus Pharmaceuticals Ltd. is part of the Trading sector and Trading industry. For investors tracking Remus Pharmaceuticals Share Price, the company profile matters because the market is reading both the price move and the listed fundamentals together. The company’s current market capitalisation is Rs 995.1 Cr, and the latest valuation metrics show a P/E ratio of 27.28, a P/B ratio of 2.87, ROE of 15.22%, ROCE of 18.64%, EPS of Rs 31.39, book value of Rs 297.86 and dividend yield of 0.12%.

In Univest coverage, that combination is useful because it frames Remus Pharmaceuticals Stock News beyond the day’s percentage move. The Trading industry benchmark is broad, with 462 companies in the same industry, so the company can be read against a meaningful peer set. Remus Pharmaceuticals Share Price therefore sits at the intersection of today’s price rise, the company’s valuation profile and the broader sector comparison. For readers following Remus Pharmaceuticals Company News, this is the clearest factual base available from Univest.

Frequently Asked Questions

Why is Remus Pharmaceuticals Share Price rising today?

Ans. According to latest Univest data, Remus Pharmaceuticals Share Price is rising today, but no company-specific catalyst is established. The stock is trading at Rs 930, up 8.61% from the previous close of Rs 856.25.

What is Remus Pharmaceuticals Share Price today?

Ans. Remus Pharmaceuticals Share Price today is Rs 930. It is up Rs 73.75, or 8.61%, and has already moved between Rs 883 and Rs 950 in the current session.

What is the market cap of Remus Pharmaceuticals Ltd.?

Ans. Remus Pharmaceuticals Market Cap stands at Rs 995.1 Cr. That places the company above the industry median of Rs 53.15 Cr and below the industry average of Rs 1,605.44 Cr.

What does Remus Pharmaceuticals fundamental analysis show?

Ans. Remus Pharmaceuticals Fundamental Analysis shows a P/E of 27.28, P/B of 2.87, ROE of 15.22%, ROCE of 18.64%, EPS of Rs 31.39 and book value of Rs 297.86. Those are the key reported figures.

How does Remus Pharmaceuticals compare with Trading sector benchmarks?

Ans. In the Trading sector, Remus Pharmaceuticals Share Price valuation is above the industry median on P/E and P/B, while ROE and ROCE are both well above the benchmark medians. The benchmark scope covers 462 companies.

How does Remus Pharmaceuticals compare with peers?

Ans. Compared with peers such as Redington Ltd., Aegis Logistics Ltd. and Premier Energies Ltd., Remus Pharmaceuticals Share Price sits in the middle on valuation and profitability. Its market cap is much smaller than the largest listed names in the set.

What is the book value of Remus Pharmaceuticals Ltd.?

Ans. Remus Pharmaceuticals book value is Rs 297.86 per share. Book value per share reflects the accounting net worth behind each share and helps place Remus Pharmaceuticals Share Price in valuation context.

What is the dividend yield for Remus Pharmaceuticals Share Price?

Ans. Remus Pharmaceuticals dividend yield is 0.12%. That is a historical payout measure, so investors generally read it alongside the share price, P/E and book value rather than in isolation.

Track Remus Pharmaceuticals Share Price on Univest

Use Remus Pharmaceuticals Ltd. (REMUS) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Investors can track Remus Pharmaceuticals Share Price on Univest for live price updates, valuation ratios, 52-week levels and company context in one place. The platform also keeps Remus Pharmaceuticals Share Price Today, sector context, peer comparison and market cap details together so the stock can be monitored without relying on scattered updates.

For those following Remus Pharmaceuticals Stock Analysis, Univest is useful because it keeps the share price, fundamental analysis and Trading sector reference points aligned. That makes it easier to review Remus Pharmaceuticals Share Price Live, compare it with peers and revisit the key numbers as the market updates through the day.